Search Results 91-100 of 18451 for total bilirubin

1. A Study To Evaluate The Safety And Efficacy Of Ombitasvir/ABT-450/Ritonavir And Dasabuvir In Adults With Genotype 1b Chronic Hepatitis C Virus (HCV) Infection And Cirrhosis - Mayo Clinic

   Total bilirubin > 3.0 mg/dL. Participating Mayo Clinic locations. Study statuses change often. Please contact the study team for the most up-to-date ...

2. A Study to Evaluate PDS0101 and Pembrolizumab Combination to Treat Subjects with HPV16 + Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma - Mayo Clinic

   institutional ULN; Hepatic: Total bilirubin ≤1.5 × ULN or direct bilirubin ≤ULN for subjects with total bilirubin levels >1.5 × ULN, AST and ALT ≤2.5 ULN ...

3. Emricasan, A Caspase Inhibitor, For Evaluation In Subjects With Non-Alcoholic Steatohepatitis (NASH) Fibrosis - Mayo Clinic

   ... bilirubin >1.5 times ULN during screening (unless subject has elevated total bilirubin due to Gilbert's as documented in the medical records); Alpha ...

4. Dose-Escalation Study of cevostamab (BFCR4350A) in Participants With Relapsed or Refractory Multiple Myeloma (R/R MM) - Mayo Clinic

   ... total bilirubin elevations are accompanied by elevated indirect bilirubin are eligible. Hematologic function (requirement prior to first dose of cevostamab):.

5. Selinexor, Daratumumab, Carfilzomib and Dexamethasone for the Treatment of High-Risk, Recurrent or Refractory Multiple Myeloma - Mayo Clinic

   - Total bilirubin =< 2.0 times the upper limit of the institutional normal values except in subjects with congenital bilirubinemia, such as Gilbert syndrome ...

6. Pembrolizumab and Binimetinib in Treating Patients With Locally Advanced or Metastatic Triple Negative Breast Cancer - Mayo Clinic

   Total bilirubin ≤ 1.5 x upper limit of normal (ULN). Aspartate transaminase (AST) and/or alanine transaminase (ALT) ≤ 2.5 x ULN or ≤ 5 x ULN for patients ...

7. A Study of Tazemetostat in Treating Patients With Recurrent Ovarian, Primary Peritoneal, or Endometrial Cancer - Mayo Clinic

   Total serum bilirubin level ≤ 1.5 x ULN; direct bilirubin ≤ ULN for subjects with total bilirubin > 1.5 x ULN (patients with isolated indirect bilirubin ...

8. Imetelstat Sodium in Treating Patients with Primary or Secondary Myelofibrosis - Mayo Clinic

   Total bilirubin ≤ 3.0 mg/dL (or direct bilirubin < 1 mg/dL); Creatinine ≤ 3.0 mg/dL; Absolute neutrophil count ≥ 1000/uL; Platelet count ≥ 50,000/uL ...

9. CTX131 in Relapsed/Refractory Hematologic Malignancies - Mayo Clinic

   Total bilirubin <2 × ULN (for Gilbert's syndrome or lymphomatous infiltration of the liver: total bilirubin <3 mg/dL). Cardiac: Hemodynamically stable and ...

10. Genetically Engineered Cells (MUC1-Activated T-Cells) for the Treatment of MUC1 Positive Recurrent or Refractory Multiple Myeloma - Mayo Clinic

    ... total Bilirubin is ≤3.0 x ULN and direct bilirubin ≤1.5 x ULN); Alanine aminotransferase (ALT) and aspartate transaminase (AST) £3 x ULN (≤5 x ULN for ...